J. Duckers

ORCID: 0000-0003-3004-279X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cystic Fibrosis Research Advances
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Neonatal Respiratory Health Research
  • Pediatric health and respiratory diseases
  • Nutrition and Health in Aging
  • Tracheal and airway disorders
  • Long-Term Effects of COVID-19
  • Adolescent and Pediatric Healthcare
  • Antifungal resistance and susceptibility
  • COVID-19 and Mental Health
  • Diabetes Management and Research
  • Bone health and osteoporosis research
  • Fibromyalgia and Chronic Fatigue Syndrome Research
  • Sinusitis and nasal conditions
  • Immunodeficiency and Autoimmune Disorders
  • Health Systems, Economic Evaluations, Quality of Life
  • Breastfeeding Practices and Influences
  • Folate and B Vitamins Research
  • Prenatal Screening and Diagnostics
  • Respiratory viral infections research
  • Antibiotic Resistance in Bacteria
  • Asthma and respiratory diseases
  • Delphi Technique in Research
  • Pregnancy and Medication Impact
  • Nematode management and characterization studies

Cardiff and Vale University Health Board
2015-2025

University Hospital Llandough
2015-2025

Cystic Fibrosis Trust
2023-2024

University Hospital of Wales
2021-2023

Public Health Wales
2023

National Health Service Wales
2021-2022

Barts Health NHS Trust
2021

University of Limerick
2020

Nottingham University Hospitals NHS Trust
2020

Bambino Gesù Children's Hospital
2019

Background Many people recovering from coronavirus disease 2019 (COVID-19) experience prolonged symptoms, particularly breathlessness. We urgently need to identify safe and effective COVID-19 rehabilitative strategies. The aim of the current study was investigate potential role inspiratory muscle training (IMT). Methods 281 adults (age 46.6±12.2 years; 88% female) self-reported (9.0±4.2 months post-acute infection) were randomised 4:1 an 8-week IMT or a “usual care” waitlist control arm....

10.1183/13993003.03101-2021 article EN cc-by-nc European Respiratory Journal 2022-03-02
Ahmet Uluer Gordon MacGregor Pilar Azevedo V. Indihar Claire Keating and 95 more Marcus Mall Edward F. McKone Bonnie W. Ramsey Steven M. Rowe Ronald C. Rubenstein Jennifer L. Taylor‐Cousar Elizabeth Tullis Lael M. Yonker Chenghao Chu Anna P. Lam Nitin Nair Patrick R. Sosnay Simon Tian Fredrick Van Goor Lakshmi Viswanathan David Waltz Linda T. Wang Yingmei Xi Joanne Billings Alex Horsley Alex Horsley E.F. Nash Marleen Bakker Eva Van Braeckel Petrus Merkus Christof J. Majoor Karen McCoy Joanne Billings Krishna Pancham James Tolle Bryon Quick Ahmet Uluer Emily DiMango A. Vijaya Rao Santiago Reyes Ross C. Klingsberg Celeste Barreto Victor E. Ortega Donna Beth Willey‐Courand C. Schwarz Sivagurunathan Sutharsan Rainald Fischer Jane C. Davies J. Duckers Alex Horsley Simon Doe E.F. Nash Marleen Bakker Harry Heijerman Eva Van Braeckel Petrus Merkus Christof J. Majoor George M. Solomon Christian A. Merlo Jennifer Griffonnet Joseph M. Pilewski Jordan Dunitz Saba Sheikh Ronald C. Rubenstein Daniel Rosenbluth Theodore G. Liou M. Indihar Krishna Pancham Lael M. Yonker Samya Z. Nasr Jennifer Griffonnet Cynthia D. Brown Gregory S. Sawicki Jennifer Ruddy Emily DiMango Bryan Garcia Andrew T. Braun Alex H. Gifford Nighat Mehdi Maria Tupayachi Ortiz Raksha Jain Francisco J. Calimano Jimmy Johannes Cori Daines Jason Fullmer Joel Mermis Christopher Barrios Ngoc P. Ly Brian Casserly Stephan Eisenmann Helge Hebestreit Alexander Kiefer Sivagurunathan Sutharsan Rainald Fischer Gordon MacGregor D. Peckham M.J. Ledson Eva Van Braeckel Petrus Merkus Noel G. McElvaney

10.1016/s2213-2600(22)00504-5 article EN cc-by-nc-nd The Lancet Respiratory Medicine 2023-02-23

Bronchiectasis is a chronic inflammatory lung disease, which has similarities to obstructive pulmonary disease (COPD). Comorbidities of COPD include increased risk cardiovascular (CV) loss bone mineral density (BMD) and skeletal muscle mass function, all linked systemic inflammation. The potential for such comorbidities not been explored in bronchiectasis. We hypothesised that patients with bronchiectasis would have similar comorbidities. A total 20 noncystic fibrosis were compared controls...

10.1177/1479972312459973 article EN Chronic Respiratory Disease 2012-11-01

Understanding of strategies to support individuals recovering from coronavirus disease 2019 (COVID-19) is limited. 'Long COVID' a multisystem characterised by range respiratory, gastrointestinal, cardiovascular, neurological, and musculoskeletal symptoms extending beyond 12 weeks. The aim this study was explore individuals' experiences COVID-19 provide better understanding the acute long-term impact on physical activity (PA). Individualised semi-structured interviews were conducted with 48...

10.3390/ijerph182111417 article EN International Journal of Environmental Research and Public Health 2021-10-29

Background Primary ciliary dyskinesia (PCD) is a rare genetic disorder characterized by dysfunction of motile cilia. Symptoms include recurrent and chronic airway infections which can lead to deteriorating lung function inflammatory destructive disease in the form persistent atelectasis bronchiectasis. Routine blood testing may be used as tool for monitoring management. However, currently there are no consensus-based guidelines within field PCD. BEAT-PCD together with ERN-LUNG PCD-Clinical...

10.1183/23120541.01071-2024 article EN cc-by-nc ERJ Open Research 2025-02-20

Background A person’s beliefs about treatment influence their engagement and adherence to that treatment. The Necessity-Concerns Framework suggests is influenced by a judgement of own need for (necessity beliefs) concerns the potential adverse consequences taking This study was conducted explore elexacaftor-tezacaftor-ivacaftor (ETI) therapy (Kaftrio) in adults with cystic fibrosis (CF). Methods total 64 CF were maintained on ETI as part routine care, completed Beliefs Medicines...

10.1136/bmjresp-2024-002546 article EN cc-by-nc-nd BMJ Open Respiratory Research 2025-03-01

Deeper understanding of mold-induced cytokine signatures could promote advances in the diagnosis and treatment invasive mycoses mold-associated hypersensitivity syndromes. Currently, most T-cellular immunoassays medical mycology require isolation mononuclear cells have limited robustness practicability, hampering their broader applicability clinical practice. Therefore, we developed a simple, cost-efficient whole blood (WB) assay with dual α-CD28 α-CD49d co-stimulation to quantify secretion...

10.3390/jof7060462 article EN cc-by Journal of Fungi 2021-06-08

To compare pregnancy rates and outcomes for women with cystic fibrosis in the UK those of general population assess effect introduction disease-modifying treatment.A population-based longitudinal study, 2003-17.United Kingdom.Women aged 15-44 years (CF) Registry compared England Wales.We calculated live-birth CF Wales. For we before after ivacaftor was introduced 2013. We further used registry data to mothers CF, relationship between maternal pre-pregnancy lung function nutritional status...

10.1111/1471-0528.16957 article EN BJOG An International Journal of Obstetrics & Gynaecology 2021-10-01

Cystic fibrosis (CF) limits survival and negatively affects health-related quality of life (HRQOL). Cost-effectiveness analysis (CEA) may be used to make reimbursement decisions for new CF treatments; nevertheless, generic utility measures in CEA, such as EQ-5D, are insensitive meaningful changes lung function HRQOL CF. Here we develop a new, disease-specific, preference-based measure based on the adolescent/adult version Fibrosis Questionnaire-Revised (CFQ-R), widely used, CF-specific,...

10.1016/j.jval.2022.12.002 article EN cc-by Value in Health 2022-12-09

Background: therapeutic drug monitoring is a crucial aspect of the management hospitalized patients. The correct dosage antibiotics imperative to ensure their adequate exposure specially in critically ill aim this study establish and validate robust fast liquid chromatography-tandem mass spectrometry (LC/MS) method for simultaneous quantification two important patients, cefiderocol meropenem human plasma. Methods: sample clean-up was performed by protein precipitation using acetonitrile....

10.1039/d2ay01459a article EN cc-by Analytical Methods 2023-01-01

In cystic fibrosis (CF) patients, Gram-negative Burkholderia cepacia complex (Bcc) infections are associated with recurrent pulmonary exacerbations. Bcc organisms innately resistant to many antibiotics, and infection B. cenocepacia is a contraindication lung transplantation. We report CF patient severe disease, colonized Bcc, history of around nine exacerbations per year for over 10 years, whom antibiotic regimens (including targeted broad-spectrum antibiotics) had not cleared or extended...

10.1099/acmi.0.000413 article EN cc-by-nc Access Microbiology 2022-10-07

Abstract Background Current guidelines for the management of bronchiectasis (BE) highlight lack evidence to recommend mucoactive agents, such as hypertonic saline (HTS) and carbocisteine, aid sputum removal part standard care. We hypothesise that agents (HTS or a combination) are effective in reducing exacerbations over 52-week period, compared usual Methods This is 52-week, 2 × factorial, randomized, open-label trial determine clinical effectiveness cost HTS 6% carbocisteine airway...

10.1186/s13063-019-3766-9 article EN cc-by Trials 2019-12-01

There are complex medical, psychological, social and economic aspects to becoming a parent with Cystic Fibrosis (CF). A shared decision-making (SDM) approach could help women CF make informed decisions about their reproductive goals that sensitive individual values preferences. This study investigated capability, opportunity, motivation participate in SDM from the perspective of CF.

10.1016/j.jcf.2023.02.007 article EN cc-by Journal of Cystic Fibrosis 2023-02-28

Abstract Aims To examine HbA 1c as a predictor of risk for future development cystic fibrosis‐related diabetes and to assess the association with retinopathy in people diabetes. Methods A 7‐year retrospective longitudinal study was conducted 50 adults fibrosis, comparing oral glucose tolerance test results values predicting Retinal screening data were also compared measurements microvascular outcome. Results An value ≥37 mmol/mol (5.5%; hazard ratio 3.49, CI 1.5–8.1) significantly associated...

10.1111/dme.13912 article EN Diabetic Medicine 2019-01-30

Cystic fibrosis (CF) is a common autosomal recessive disorder in Caucasian populations with respiratory, gastrointestinal and endocrine manifestations. Thanks to recent advances medical therapies infection control, life expectancy of patient CF has significantly increased from less than 5 years the mid-1900s almost 50 nowadays. However, as patients are living longer, multimorbidity Hyperpharmacotherapy becoming more common. This case illustrates cascade problems that ensued medication...

10.1016/j.rmcr.2015.09.013 article EN cc-by-nc-nd Respiratory Medicine Case Reports 2015-01-01
Coming Soon ...